EP
NVAX icon

Edgestream Partners’s Novavax NVAX Stock Holding History

Edgestream Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
559,796
+39,661
+8% +$355K 0.16% 225
2026
Q1 		$4.23M Buy
+520,135
New +$4.71M 0.14% 287
2024
Q4 		– Sell
-125,114
Closed -$1.58M – 1019
2024
Q3 		$1.58M Buy
+125,114
New +$1.62M 0.07% 470
2024
Q2 		– Sell
-12,753
Closed -$61K – 980
2024
Q1 		$61K Buy
12,753
+2,447
+24% +$11.3K ﹤0.01% 783
2023
Q4 		$49.5K Sell
10,306
-2,169
-17% -$13.3K ﹤0.01% 800
2023
Q3 		$90.3K Buy
+12,475
New +$99.7K 0.01% 796
2023
Q2 		– Sell
-15,741
Closed -$109K – 859
2023
Q1 		$109K Buy
+15,741
New +$145K 0.01% 532

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Edgestream Partners's NVAX Position: Q2 2026 in Review

Edgestream Partners increased its Novavax (NVAX) stake by 7.6% in Q2 2026, buying an estimated $355K and bringing the position to 559,796 shares worth $5.27M. The position accounts for 0.16% of the portfolio, ranked #225.

Edgestream Partners first reported a position in NVAX in Q1 2023 and has held it in 7 quarters since. 265 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Edgestream Partners held 559,796 shares of Novavax worth $5.27M as of Q2 2026.
  • Edgestream Partners bought 39,661 Novavax shares in Q2 2026, an estimated $355K.
  • Novavax made up 0.16% of Edgestream Partners's portfolio in Q2 2026, its #225 holding.
  • Edgestream Partners first reported a position in Novavax in Q1 2023 and has held it in 7 quarters since.
  • 265 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.